Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer. [electronic resource]
Producer: 20151112Description: 267-79 p. digitalISSN:- 1573-7217
- Aged
- Antineoplastic Agents, Hormonal -- economics
- Aromatase Inhibitors -- economics
- Breast Neoplasms -- drug therapy
- Canada
- Chemotherapy, Adjuvant -- economics
- Cost-Benefit Analysis
- Drug Costs
- Female
- Humans
- Markov Chains
- Middle Aged
- Postmenopause
- Quality-Adjusted Life Years
- Receptors, Estrogen -- metabolism
- Tamoxifen -- economics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.